Washington, DC. – If you’ve ever been in the unfortunate situation of being hospitalized, or better chances, caring for someone in the hospital, there is one thing that is certain – they are noisy places. When patients don’t sleep well, or at all, they don’t heal. With patient centricity on the rise, hospitals, and companies catering to hospitals are attempting to make well care a better experience.

While hospitals continue to evolve in design (i.e. more private rooms), one company, Sen Sound, is attempting to champion the thought of changing, not removing, the typical sounds within a hospital setting, by creating a new soundscape within the hospital setting.

Research shows some hospitals were found to have noise over 100 decibels at night, which is as loud as a chainsaw. The World Health Organization recommends levels 30 or less for sleeping.


Sen Sound is also making it a goal to bring palliative care as a focus with their Sound Will Project, which is now a top 10 finalist for the OpenIDEO End of Life Challenge.

Why this matters:

In a world where most company’s innovational focus is trying to create something brand new to introduce to the market, this is a simple idea to present a slight change to how the much needed machines patients rely on to heal translate sound into a better patient experience. With music & art therapy on the rise, this is a great example of integrating proven methods to help patients heal quicker and in turn reduce hospital stays.

About the Author:

As Strategist of Innovation, Drew is charged daily with championing innovative thinking and doing. Drew is part of a global team that leads new innovative ideas that attract different advocates among existing and potential brands that are shared across all agency partners. Drew is backed by over 16 years of brand, sales and marketing experience with Fortune 500 companies such as Progressive and Nationwide Insurance as well as Founder & President of his own healthcare insurance agency for 6 years. Most recently Drew was part of the agency team that launched Briviact for UCB, Foundation Medicine as well as key roles with Eli Lilly Oncology and Johnson & Johnson.